INSM Q1 2020 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena

INSMInsmed Incorporated

$30B

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$37M+68.3% YoY

Gross Profit

$28M77.1% margin

Operating Income

-$60M-163.7% margin

Net Income

-$66M-180.0% margin

EPS (Diluted)

$-0.74

QoQ Revenue Growth

-19.4%

Cash Flow

Operating Cash Flow

-$58M

Free Cash Flow

-$61M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$677M

Total Liabilities

$470M

Stockholders' Equity

$207M

Cash & Equivalents

$429M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$37M	$22M	+68.3%
Gross Profit	$28M	$18M	+60.1%
Operating Income	-$60M	-$70M	+13.2%
Net Income	-$66M	-$74M	+10.5%